1.
Int J Med Microbiol
; 291(3): 237-9, 2001 Aug.
Article
in English
| MEDLINE
| ID: mdl-11554565
ABSTRACT
The conventional treatment of staphylococcal endocarditis requires in-patient administration, is inconvenient, and is potentially toxic. Increasing experience with well-absorbed, well-tolerated and highly active agents such as the new quinolones has prompted interest in their use as therapeutic alternatives for the treatment of such infections. We describe a case of staphylococcal endocarditis which failed to respond to conventional therapy, but where the addition of moxifloxacin, an 8-methoxyquinolone, was curative.
Subject(s)
Anti-Infective Agents/therapeutic use , Aza Compounds , Endocarditis, Bacterial/drug therapy , Fluoroquinolones , Quinolines , Staphylococcus aureus/isolation & purification , Adult , Endocarditis, Bacterial/microbiology , Humans , Male , Moxifloxacin , Staphylococcal Infections/drug therapy
2.
J Antimicrob Chemother
; 44(4): 581-2, 1999 Oct.
Article
in English
| MEDLINE
| ID: mdl-10588329
Subject(s)
Anti-Bacterial Agents/therapeutic use , Clindamycin/therapeutic use , Erythromycin/therapeutic use , Macrolides , Staphylococcal Infections/drug therapy , Anti-Bacterial Agents/pharmacology , Drug Resistance, Microbial , Humans , Lincosamides , Microbial Sensitivity Tests , Virginiamycin/pharmacology
3.
J Antimicrob Chemother
; 22(6): 952-3, 1988 Dec.
Article
in English
| MEDLINE
| ID: mdl-3072333